Cargando…
CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
CD133 has been implicated as a cancer stem cell (CSC) surface marker in several malignancies including pancreatic cancer. However, the functional role of this surface glycoprotein in the cancer stem cell remains elusive. In this study, we determined that CD133 overexpression induced “stemness” prope...
Autores principales: | Nomura, Alice, Banerjee, Sulagna, Chugh, Rohit, Dudeja, Vikas, Yamamoto, Masato, Vickers, Selwyn M., Saluja, Ashok K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480754/ https://www.ncbi.nlm.nih.gov/pubmed/25829252 |
Ejemplares similares
-
Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015) -
Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2016) -
Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133(+) tumor initiating cells
por: Nomura, Alice, et al.
Publicado: (2016) -
MUC1c Regulates Cell Survival in Pancreatic Cancer by Preventing Lysosomal Permeabilization
por: Banerjee, Sulagna, et al.
Publicado: (2012) -
miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
por: Chen, Zhiyu, et al.
Publicado: (2013)